BenjaminLT, RogersAM, RosenbaumA. Coca-Cola, caffeine, and mental deficiency: Harry Hollingworth and the Chattanooga trial of 1911. J Hist Behav Sci. 1991; 27:42–55.
2.
CappellettiS, PiacentinoD, FineschiV, FratiP, CipolloniL, AromatarioM. Caffeine-related deaths: Manner of deaths and categories at risk. Nutrients. 2018; 10:1–13.
3.
Lopez-garciaE, Dam RMVan, LiTY, Rodriguez-artalejoF, HuFB. The relationship of coffee consumption with mortality. Ann Intern Med. 1986; 148:904–914.
4.
FreedmanND. Association of coffee drinking with total and all cause mortality. N Engl J Med. 2012; 366:1891–1904.
5.
PostumaRB, LangAE, MunhozRP, et al.Caffeine for treatment of Parkinson disease: A randomized controlled trial. Neurology. 2012; 79:651–658.
6.
RossGW, AbbottRD, PetrovitchH, et al.Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000; 283:2674–2679.
7.
KolahdouzanM, HamadehMJ. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci Ther. 2017; 23:272–290.
8.
RitchieK, CarrieI. The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology. 2007; 69:536–545.
9.
MartiniD, Del Bo’C, TassottiM, et al.Coffee consumption and oxidative stress: A review of human intervention studies. Molecules. 2016; 21:pii: E979.
FengR, LuY, BowmanLL, QianY, CastranovaV, DingM. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem. 2005; 280:27888–27895.
12.
GoodmanBA, OpitzSEW, SmrkeS, YeretzianC. Engineering the composition of coffee to potentially improve its health benefits. J Nutr Diet. 2018; 1:1–9.
13.
SocodatoR, PortugalCC, CanedoT, et al.c-Src deactivation by the polyphenol 3-O-caffeoylquinic acid abrogates reactive oxygen species-mediated glutamate release from microglia and neuronal excitotoxicity. Free Radic Biol Med. 2014; 79C:45–55.
14.
BoettlerU, VolzN, PahlkeG, et al.Coffees rich in chlorogenic acid or N-methylpyridinium induce chemopreventive phase II-enzymes via the Nrf2/ARE pathway in vitro and in vivo. Mol Nutr Food Res. 2011; 55:798–802.
15.
DomithI, Duarte-SilvaAT, Gustavo GarciaC, da Costa CalazaK, Paes-de-CarvalhoR, CossenzaM. Chlorogenic acids inhibit glutamate dehydrogenase and decrease intracellular ATP levels in cultures of chick embryo retina cells. Biochem Pharmacol. 2018; 155:393–402.
16.
LoftfieldE, CornelisMC, CaporasoN, YuK, SinhaR, FreedmanN. Association of coffee drinking with mortality by genetic variation in caffeine metabolism findings from the UK Biobank. JAMA Intern Med. 2018; 178:1086–1097.
17.
RodriguesNP, BragagnoloN. Identification and quantification of bioactive compounds in coffee brews by HPLC-DAD-MSn. J Food Compos Anal. 2013; 32:105–115.
